[go: up one dir, main page]

IL109626A0 - Stable quinolone and naphthydridine premix formulations - Google Patents

Stable quinolone and naphthydridine premix formulations

Info

Publication number
IL109626A0
IL109626A0 IL10962694A IL10962694A IL109626A0 IL 109626 A0 IL109626 A0 IL 109626A0 IL 10962694 A IL10962694 A IL 10962694A IL 10962694 A IL10962694 A IL 10962694A IL 109626 A0 IL109626 A0 IL 109626A0
Authority
IL
Israel
Prior art keywords
naphthydridine
quinolone
stable
premix formulations
premix
Prior art date
Application number
IL10962694A
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL109626A0 publication Critical patent/IL109626A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL10962694A 1993-05-15 1994-05-11 Stable quinolone and naphthydridine premix formulations IL109626A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6244793A 1993-05-15 1993-05-15

Publications (1)

Publication Number Publication Date
IL109626A0 true IL109626A0 (en) 1994-08-26

Family

ID=22042549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10962694A IL109626A0 (en) 1993-05-15 1994-05-11 Stable quinolone and naphthydridine premix formulations

Country Status (4)

Country Link
AU (1) AU6832394A (en)
IL (1) IL109626A0 (en)
WO (1) WO1994026110A1 (en)
ZA (1) ZA943317B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (en) 1997-12-05 1999-06-10 Upjohn Co QUINOLON MAGNESIUM ANTIBIOTIC COMPOUNDS
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
GR1008168B (en) * 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831514A1 (en) * 1988-09-16 1990-03-22 Bayer Ag PH NEUTRAL WAESSED SOLUTIONS OF CHINOLO CARBON ACIDS
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids

Also Published As

Publication number Publication date
ZA943317B (en) 1995-01-23
WO1994026110A1 (en) 1994-11-24
AU6832394A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
IL111978A0 (en) Dry-compressed paroxetine formulations and their preparation
IL106109A0 (en) Vaccine compositions and their manufacture
GB2294465A8 (en) Perfluoroelastomeric compositions and methods
EP0721328A4 (en) Camptothecin formulations
AU4939693A (en) Combination pin pad and terminal
AP9901623A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
GB9121289D0 (en) Composition and use
AU5494294A (en) Hop extract and use thereof
ZA9410235B (en) Slow-release insect-repellent formulations and uses
GB9410252D0 (en) Galenic formulations
GB9214390D0 (en) Formulations
ZA924491B (en) Compositions and use thereof
IL109626A0 (en) Stable quinolone and naphthydridine premix formulations
GB9203517D0 (en) Composition and use
GB9722958D0 (en) Galenical formulations
GB9306456D0 (en) Composition and use
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
GB9216776D0 (en) Composition and use
GB9303098D0 (en) Burner plaque
GB9408859D0 (en) Composition and use
GB9416404D0 (en) New use and formulations
ZA952801B (en) New use and formulations
ZA948902B (en) P-Hydroxyaniline derivatives their preparation and their use
ZA948901B (en) P-hydroxyaniline derivatives their preparation and their use